Kazakhstan will likely acquire the Pfizer vaccine against the coronavirus disease no earlier than the second half of 2021, Health Minister Alexey Tsoy said Sunday.
"We discussed [with Pfizer] the issues of possible shipment of those vaccines, [as well as] the price. We signed a nondisclosure agreement, [so] we cannot divulge some information ... but it has been proposed that this vaccine may appear in Kazakhstan no earlier than the second half of the year," Tsoy said at a press conference.
In December, the Kazakh government said that it would start vaccinating people with its own QazCovid-in vaccine, which is currently undergoing Phase 3 clinical trials, in March. The country has also started. Meanwhile, on December 21, the production of the Russia-developed Sputnik V vaccine started at Karaganda Pharmaceutical Complex in central Kazakhstan. (/Sputnik)
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor